key: cord-0727731-b9ywrmfn
authors: Li, Zhong-Jie; Yu, Lin-Jie; Zhang, Hai-Yang; Shan, Chun-Xi; Lu, Qing-Bin; Zhang, Xiao-Ai; Ren, Xiang; Zhang, Cui-Hong; Wang, Yi-Fei; Lin, Sheng-Hong; Xu, Qiang; Jiang, Bao-Gui; Jiang, Tao; Lv, Chen-Long; Chen, Jin-Jin; Gao, George F; Yang, Wei-Zhong; Wang, Li-Ping; Yang, Yang; Fang, Li-Qun; Liu, Wei
title: Broad impacts of COVID-19 pandemic on acute respiratory infections in China: an observational study
date: 2021-11-12
journal: Clin Infect Dis
DOI: 10.1093/cid/ciab942
sha: 439b09d00599dbc04932be7fc411005e3e3ccc52
doc_id: 727731
cord_uid: b9ywrmfn

BACKGROUND: To combat the COVID-19 pandemic, nonpharmaceutical interventions (NPI) were implemented worldwide, which impacted a broad spectrum of acute respiratory infections (ARI). METHODS: Etiologically diagnostic data from 142 559 cases with ARIs, who were tested for eight viral pathogens (influenza virus, IFV; respiratory syncytial virus, RSV; human parainfluenza virus, HPIV; human adenovirus; human metapneumovirus; human coronavirus, HCoV; human bocavirus, HBoV, and human rhinovirus, HRV) between 2012 and 2021, were analyzed to assess the changes of respiratory infections in China during the first COVID-19 pandemic year compared to pre-pandemic years. RESULTS: Test positive rates of all respiratory viruses decreased during 2020, compared to the average levels during 2012−2019, with changes ranging from -17·2% for RSV to -87·6% for IFV. Sharp decreases mostly occurred between February and August when massive NPIs remained active, although HRV rebounded to the historical level during the summer. While IFV and HMPV were consistently suppressed year round, RSV, HPIV, HCoV, HRV HBov resurged and went beyond historical levels during September, 2020−January, 2021, after NPIs were largely relaxed and schools reopened. Resurgence was more prominent among children younger than 18 years and in Northern China. These observations remain valid after accounting for seasonality and long-term trend of each virus. CONCLUSIONS: Activities of respiratory viral infections were reduced substantially in the early phases of the COVID-19 pandemic, and massive NPIs were likely the main driver. Lifting of NPIs can lead to resurgence of viral infections, particularly in children.

In response to the ongoing pandemic of the 2019 novel coronavirus disease (COVID- 19) , each country has implemented its own portfolio of public health interventions to mitigate the impact of the pandemic. During the first pandemic year, preventive interventions were mostly nonpharmaceutical (social distancing, mask-wearing, shelter-in-place, travel restrictions, school closure, etc.) while vaccines targeting SARS-CoV-2, the etiological pathogen for COVID-19, were being developed [1] . Nonpharmaceutical measures are known to act on a broad spectrum of respiratory pathogens [2] [3] [4] [5] , and studies have explored the impact of the COVID-19 related nonpharmaceutical interventions (NPIs) on respiratory infections [6] [7] [8] [9] , with most studies not including the time following the lifting of NPIs. Several studies for long-term impact of NPI in late 2020 have been done on the circulation level of influenza and other viral respiratory infections in North America [10, 11] , tropical Asia [12] , Europe [13] , Japan [14, 15] and South Korea [16] , where a common finding was that influenza decreased.

However, in China, where COVID-19 was first reported and quickly controlled, the trends of common ARIs spectrum during and after the first epidemic wave remain largely uninvestigated.

In China, a nationwide Surveillance for Etiology of Respiratory Infections (SERI) program has been implemented by the Chinese Center for Disease Control and Prevention (China CDC) since 2009, testing a spectrum of common contagious pathogens causing acute respiratory infections (ARI) year round in 31 provinces [17] . A previous study based on SERI found that virus positive rates varied greatly across age groups and geographical regions [17] . While NPIs were more or less uniform in mainland China during the first wave, their effects might differ by age group and region. For example, closure and reopening of schools mainly affected children, and differences in seasonality of respiratory viruses, culture and contact behavior might lead to differential responses to the NPIs between southern and northern provinces [18] . Using the unique data collected by SERI, we characterize the circulation patterns of the ARI viruses before, during and after the first wave of COVID-19 in the 5 / 29 mainland of China as a whole as well as by age group and region. Dynamic changes of these patterns are informative about the broad impact of the NPIs on respiratory infections that share similar transmission modes.

A total of 314 sentinel hospitals covering all 31 provinces across the mainland of China participated in the SERI project. During Jan 2012−Jan 2021, nasopharyngeal specimens from a random sample of inpatients and outpatients presenting ARIs at these hospitals were collected prior to any treatment. These samples were tested for the presence of eight viral pathogens including influenza virus (IFV), respiratory syncytial virus (RSV), human parainfluenza virus (HPIV), human adenovirus (HAdV), human metapneumovirus (HMPV), human coronavirus (HCoV), human bocavirus (HBoV) and human rhinovirus (HRV) [19] .

IFV, RSV, HPIV, HMPV, HCoV, and HRV were tested by RT-PCR, and HAdV and HBoV were tested by PCR according to the standard operating protocol (SOP) of surveillance developed by China CDC. The SERI program included SARS-CoV-2 test from January 2020 and the test results were documented separately. SARS-CoV-2 positive patients were excluded from the current analysis. Details about the SERI program are given in the supplementary materials.

To demonstrate the impact of NPIs on the circulation patterns of the pathogens, we define three periods according to the timeline of major intervention events for containing the COVID-19 epidemic in China: Jan 23 rd to Apr 7 th 2020 (Phase I) when Wuhan city was placed under lockdown, Apr 8 th to Aug 31 st 2020 (Phase II) when nationwide NPIs were relaxed while schools remained closed, Sep 1 st 2020 to Jan 22 nd 2021 (Phase III) when schools were re-opened in most provinces. The details of NPIs implemented during the three phases were included in Supplementary Materials. To attain a controlled comparison with historical levels, the same periods were also defined based on corresponding calendar intervals for pre-pandemic years, starting from Jan 23 rd , 2012 to Jan 22 nd 2020.

Positive rates were then compared between average of pre-pandemic years and the pandemic year for each period, using the percent change calculated as:

where is the positive rate during phase k of the pandemic year, Jan 23 rd 2020 to proportion of patients aged from 0 to 17, 18 to 59 and over 60 years old respectively during the whole pre-pandemic and pandemic years. The comparison was also conducted by age group, sex, geographic region and clinical type (pneumonia and non-pneumonia cases).

Time series of monthly positive rates were plotted and fitted with generalized linear models (GLM) to quantify the impact of the COVID-19 related NPIs in different periods for each virus, stratified by age groups (0-17 years old and ≥18 years old) and geographic regions (south and north of China, Supplementary Figure 1A ). The periods were redefined for the monthly data, with phases I−III corresponding to February−March, April−August and September-January respectively. We assumed the number of positive cases in each month followed a beta-binomial distribution. This assumption accounts for overdispersion and also

considers the limited numbers of tested specimens when the data are stratified by region and age group [20, 21] . The effect of NPIs was coded by three dummy indicators for four phases, with phases I−IV corresponding to Jan 2012-Jan 2020, Feb 2020-Mar 2020, Apr 2020-Aug 2020, and Sep 2020-Jan 2021, respectively. Seasonality was accounted for using sinusoidal functions with both annual and semiannual cycles [22] . Calendar year was included as a covariate to capture the long-term trend, and its functional format could be linear, quadratic or discrete, depending on the AIC. When the discrete year effect was chosen, i.e., each year had its own intercept, we assumed the years 2019 and 2020 share the same intercept, so that the effect of NPIs is estimable. We reported exponentiated regression coefficients as seasonalityadjusted odds ratios (OR). Statistical significance was evaluated with two-sided p-values at the level of α = 5%. All statistical analyses were conducted in the R software (version 4.0.3, R Development Core Team 2020).

We extracted diagnostic results and epidemiological data of 104 652 cases with ARI who were tested for the eight respiratory viruses over the period Jan 23, 2012-Jan 31, 2021. The annual number of tested ARI cases decreased from an average of 12 108 during the prepandemic years to 7 783 during the pandemic year (Supplementary Figure 1B) . The baseline characteristics of the patients were compared between the two periods in Supplementary Figure 2 ).

The largest drop of annual cumulative positive rate was observed for IFV, a reduction of 87.6% (from 9.94% to 1.23%), followed by 70.6% (1.63% to 0.48%) for HMPV, 47% (3.98% to 2.11%) for HAdV, and 32.3% (5.11% to 3.46%) for HPIV.

The change patterns differed across the three phases (Table 1, Supplementary Table 2 and Supplementary Figure 1 ). Dramatic reductions in positive rates were seen for most including reopening of schools. HAdV returned to the pre-pandemic level ( Table 1) . Table 3 ).

Positive rates of IFV, HPIV and HMPV decreased significantly from pre-pandemic years to

the pandemic year in all three age groups ( Figure 1 A−C). For HRV, RSV and HBoV, positive rates were significantly reduced in adults (≥18 years) but not in children (<18 years).

The declines of positive rates during the first two phases were similar in all three age groups, except for the increased activity of HRV among children during Phase II. During Phase III, the activities of RSV, HPIV, HCoV and HBoV among children resurged to be substantially above historical levels, and the circulation of HRV, HAdV and HMPV also nearly reached historical levels. In particular, the higher than historical levels of RSV, HPIV, HCoV and HBoV in Phase III observed for the whole population (Supplementary Figure 2) were mostly attributed to their resurgence in children ( Figure 1A ). Among adults ≥18 years, activities of HPIV, HAdV and HCoV also returned to their historical levels during period III ( Figure 1B , Figure 1C ).

The change patterns were largely consistent between the two sexes ( Figure 2A) ; however, they did differ to some extent between Northern China and Southern China, especially during Phase III. Positive rates of HRV and HAdV increased significantly in the North but decreased significantly in the South during the Phase III ( Figure 2B ). In addition, more increases of RSV, HPIV, HCoV and HBoV were seen in the North than in the South during Phase III. No regional difference was seen for IFV and HMPV. The resurgence of HPIV and HCoV was more associated with patients without pneumonia, whereas the resurgence of HBoV was more associated with pneumonia patients, during Phase III ( Figure   2C ).

We fitted generalized linear models (GLM) to temporal trajectories of monthly positive rates of the viruses by age group (Figure 3 ) and by region, South vs. North (Supplementary Figure   5 ). As the change patterns of virus positive rate were similar between adults (18-59 years) and older adults (≥60 years) in all phases ( Figure 1B , Figure 1C ). We therefore combined the The pattern of the phase-specific ORs (Table 2 ) was further revealed largely consistent with that of the percentage changes in Figure 1 and Figure 2 , with some subtle differences. RSV significantly increased its activity in both the South and the North, but age-standardized percent changes in Figure 2B In contrast to most other respiratory pathogens, the activity of influenza viruses remained lower than historical levels consistently throughout the pandemic year, regardless of region and age group. Similar situations were found in other countries on both Northern and Southern Hemispheres [4, 11] . A possible reason is the greatly reduced regional and international travel during the pandemic. It has long been recognized that domestic and international air travels likely play an important role in the spread of IFV from the tropical zones towards subtropical and temperate zones in winters [24] [25] [26] . Towards the end of 2020, international travel was far from recovered. Although domestic travel essentially returned to normal in many countries, but some NPIs such as mask wearing and social distancing were still in place in transportation hubs, which could be highly effective against influenza which was mainly transmitted via droplets and fomites. For example, a study found that wearing masks could effectively block the transmission of IFV and HCoV but might be less effective in blocking HRV [27] . In addition to travel restrictions and NPIs, interactions among respiratory viruses might have also played a role. For example, infection with HRV was shown to reduce the risk of infection with IFV [28, 29] . On the other hand, influenza vaccine was unlikely a plausible reason for the reduced IFV transmission, as the vaccine coverage rate had been significantly reduced in China during the COVID-19 pandemic [30] . This study has several limitations. Firstly, causality between viral activity and NPI measures cannot be inferred from the surveillance data. Secondly, the COVID-19 pandemic might have substantially changed healthcare-seeking behavior of patients with ARIs. While the inclusion/exclusion criteria for the testing stayed the same during the pandemic, the total number of tests did decrease, likely a result of reduced healthcare seeking behavior during the pandemic [31] . Our analyses were based on test-positive rate which should be less sensitive to healthcare-seeking behavior, but it cannot be ruled out that the pandemic has shifted the profile of people who seek medical assistance for ARIs.

In future public health emergencies, interruptive NPIs may serve as a frontline control before efficacious vaccines become ready. When it is possible or necessary to lift the NPIs, 

The authors would like thank all the subjects, their families, and collaborating clinicians for their participation. We thank staff members of the Department of Science and Education of the National Health Commission, and the ARIs surveillance network laboratories and sentinel hospitals in the participating 31 provinces of China for assistance with field investigation, administration, and data collection. Potential conflicts of interest.

Disclosure of Potential Conflicts of Interest. 

Division of Infectious Disease, Key Laboratory of Surveillance and Early-warning on Infectious Disease, Chinese Center for Disease Control and Prevention

National Institute for Viral Disease Control and Prevention

The Institute for Disease Prevention and Control of PLA

Inner Mongolia Autonomous Region Comprehensive Center for Disease Control and Prevention

The Third People's Hospital of Shenzhen

An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China

Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand

COVID-19 and infant hospitalizations for seasonal respiratory virus infections

The impact of COVID-19 public health measures on detections of influenza and respiratory syncytial virus in children during the 2020 Australian winter

Different transmission dynamics of COVID-19 and influenza suggest the relative efficiency of isolation/quarantine and social distancing against COVID-19 in China

Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study

Seasonal influenza activity during the SARS-CoV-2 outbreak in Japan

COVID-19 public health measures and respiratory syncytial virus

Effects of COVID-19 prevention measures on other common infections

The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario

Changes in seasonal respiratory illnesses in the United States during the COVID-19 pandemic

Re-emergence of influenza virus circulation during 2020 in parts of tropical Asia: Implications for other countries

Very little influenza in the WHO European Region during the 2020/21 season

Mycoplasma pneumoniae pneumonia and respiratory syncytial virus infection in Japan during the severe acute respiratory syndrome coronavirus 2 pandemic

Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic

Trends in viral respiratory infections during COVID-19 pandemic

Etiological and epidemiological features of acute respiratory infections in China

Characterization of regional influenza seasonality patterns in China and implications for vaccination strategies: spatio-temporal modeling of surveillance data

Pathogen surveillance and detection techniques: Febrile respiratory syndrome (in Chinese)

Evaluation of seasonal respiratory virus activity before and after the statewide COVID-19 shelter-in-place order in Northern California

Comparison of beta-binomial regression model approaches to analyze health-related quality of life data

Analysing seasonal data

How COVID-19 is changing the cold and flu season

Effect of travel on influenza epidemiology

Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States

Human mobility and the global spread of infectious diseases: a focus on air travel

Respiratory virus shedding in exhaled breath and efficacy of face masks

Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study

Virus-virus interactions impact the population dynamics of influenza and the common cold

The influence of the COVID-19 epidemic on prevention and vaccination behaviors among Chinese children and adolescents: cross-sectional online survey study

The impact of the COVID-19 pandemic on health services utilization in China: Time-series analyses for 2016-2020